Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
IOB - Delayed Quote EUR

Evotec SE (0IRF.IL)

Compare
5.55
-0.32
(-5.38%)
At close: April 4 at 5:45:04 PM GMT+1
Advanced Chart
Loading Chart for 0IRF.IL
  • Previous Close 5.86
  • Open 5.91
  • Bid 5.32 x --
  • Ask 5.65 x --
  • Day's Range 5.36 - 5.91
  • 52 Week Range 4.90 - 14.62
  • Volume 77,409
  • Avg. Volume 48,399
  • Market Cap (intraday) 1.077B
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.58
  • Earnings Date Apr 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

www.evotec.com

5,067

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

More about Evotec SE

Recent News: 0IRF.IL

View More
View More

Performance Overview: 0IRF.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

0IRF.IL
34.98%
DAX P (^GDAXI)
3.68%

1-Year Return

0IRF.IL
60.65%
DAX P (^GDAXI)
12.16%

3-Year Return

0IRF.IL
80.25%
DAX P (^GDAXI)
42.18%

5-Year Return

0IRF.IL
73.34%
DAX P (^GDAXI)
116.69%

Compare To: 0IRF.IL

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

0IRF.IL
Evotec SE
5.55
-5.38%
Mkt Cap EUR 1.077B
Industry Drug Manufacturers—Specialty & Generic
PA8.SG
PAION AG
0.0196
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic

Statistics: 0IRF.IL

View More

Valuation Measures

Annual
As of 4/4/2025

  • Market Cap

    979.21M

  • Enterprise Value

    1.07B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.26

  • Price/Book (mrq)

    1.01

  • Enterprise Value/Revenue

    1.38

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.94%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    -8.43%

  • Revenue (ttm)

    798.41M

  • Net Income Avi to Common (ttm)

    -103.3M

  • Diluted EPS (ttm)

    -0.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    620.85M

  • Total Debt/Equity (mrq)

    45.49%

  • Levered Free Cash Flow (ttm)

    -202.93M

View More

Research Analysis: 0IRF.IL

View More
View More

Company Insights: 0IRF.IL

Research Reports: 0IRF.IL

View More
View More

People Also Watch

0MTD.IL Swedish Orphan Biovitrum AB (publ)
275.60
-2.44%
 
0ND5.IL H. Lundbeck A/S
30.38
-5.83%
 
0A0D.IL Alcon Inc.
73.25
-8.44%
 
0O59.IL Sanofi
97.29
-2.29%
 
0QLR.IL Novartis AG
92.92
-5.40%
 
0MV5.IL Eurofins Scientific SE
49.59
-0.03%
 
0RDU.IL Grifols, S.A.
8.20
-2.35%
 
0LNG.IL Koninklijke Philips N.V.
20.67
-6.05%
 
0MH6.IL Ipsen S.A.
104.04
-3.84%
 
0HQ8.IL Arjo AB (publ)
34.50
-0.98%
 
0QIU.IL Novo Nordisk A/S
438.55
-3.90%
 
0DNH.IL Atos SE
0.0038
-6.17%
 
0GTN.IL BioGaia AB (publ)
102.00
-5.99%
 
0H9X.IL Fresenius Medical Care AG
46.05
-1.17%
 
0HAZ.IL Capgemini SE
127.30
-5.35%
 
0NW4.IL SAP SE
231.30
-3.94%